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Abstract
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of motor neurons resulting in a catastrophic loss of
motor function. Current therapies are severely limited owing to a poor mechanistic understanding of the pathobiology.
Mutations in a large number of genes have now been linked to ALS, including SOD1, TARDBP (TDP-43), FUS and C9orf72.
Functional analyses of these genes and their pathogenic mutations have provided great insights into the underlying disease
mechanisms. Defective axonal transport is hypothesized to be a key factor in the selective vulnerability of motor nerves due
to their extraordinary length and evidence that ALS occurs as a distal axonopathy. Axonal transport is seen as an early
pathogenic event that precedes cell loss and clinical symptoms and so represents an upstream mechanism for therapeutic
targeting. Studies have begun to describe the impact of a few pathogenic mutations on axonal transport but a broad survey
across a range of models and cargos is warranted. Here, we assessed the axonal transport of different cargos in multiple
Drosophila models of ALS. We found that axonal transport defects are common across all models tested, although they often
showed a differential effect between mitochondria and vesicle cargos. Motor deficits were also common across the models
and generally worsened with age, though surprisingly there was not a clear correlation between the severity of axonal
transport defects and motor ability. These results further support defects in axonal transport as a common factor in models
of ALS that may contribute to the pathogenic process.
Introduction
Amyotrophic lateral sclerosis (ALS) is a typically adult onset
progressive neurodegenerative disorder and the most common
form of motor neuron disease. It is characterized by the loss of
both the upper and lower motor neurons representing a cata-
strophic loss of motor function. The condition is fatal, usually
due to respiratory failure, with an average life expectancy of 3–5
years from diagnosis (1). There is no cure and current therapies
are severely limited owing to a poor mechanistic understanding
of the pathobiology. Although the majority of ALS cases is spo-
radic, 10% are monogenic, familial forms. A large number of
genes have now been linked to ALS, including SOD1, TARDBP
(TDP-43), FUS and C9orf72. Functional analyses of these genes
and pathogenic mutations have provided great insight into the
underlying disease mechanisms (1,2).
TDP-43 is a multi-functional DNA/RNA-binding protein that
shuttles between the nucleus and cytoplasm (3). In the nucleus,
it plays many roles in transcription and RNA processing (4–7). In
the cytoplasm, TDP-43 localizes to stress granules, P-bodies and
RNA transport granules, and is involved in the regulation and
spatial distribution of RNAs (8–12). FUS is also a DNA/RNA-bind-
ing protein that undergoes nuclear/cytoplasmic shuttling, with
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functions in RNA processing (13,14). The targets of TDP-43 and
FUS RNA processing number in the thousands in animal mod-
els, although there appears to be only limited overlap (13,15).
However, TDP-43 and FUS targets show some functional com-
monality suggesting defects in TDP-43 or FUS function could
lead to common pathogenic outcomes (15,16).
Expansion of a hexanucleotide repeat GGGGCC in the first in-
tron of C9orf72 is the most common genetic cause of ALS (17,18).
Bidirectional transcription of these repeats forms nuclear RNA
foci which sequester RNA-binding proteins (RBPs) (17,19–24).
Moreover, these repeats undergo repeat associated non-ATG
(RAN) translation, giving rise to a series of dipeptide repeat pro-
teins (DPRs). These DPRs have a high propensity to aggregate
and form inclusions in C9orf72 associated patient tissue (25–28).
Recent research has suggested that pathogenicity is specifically
associated with arginine containing DPRs (29,30).
These insights into the molecular causes of ALS, however,
still do not provide a clear rationale for the selective cell-type
vulnerability implicit in the disease. A defining feature of motor
neurons is the extraordinary length of their axons. This charac-
teristic, coupled with evidence indicating that ALS occurs as a
distal axonopathy, has led to defective axonal transport being
implicated as a key initiating contributor to the selective vulner-
ability of motor nerves. Emerging evidence has begun to high-
light the impact of pathogenic mutations on axonal transport.
For example, expression of mutant SOD1 in motor nerves
causes axonal transport defects as an early pathology that pre-
cedes cell loss and clinical symptoms (31,32). Multiple types of
cargo are affected including mitochondria (33), neurofilaments
(32) and vesicles (34). Overexpression of the wild-type and sev-
eral pathogenic mutant TDP-43 proteins leads to early onset mi-
tochondrial transport dysfunction (35,36); however, this was not
observed in another study (8). Thus, further work remains to be
done to elucidate the relationship between axonal transport
and degeneration in TDP-43 and other ALS models.
Here, we analyzed fast axonal transport in larval motor neu-
rons of Drosophila models of TARDBP (TDP-43), FUS and C9orf72.
We also analyzed the effect of loss-of-function mutants of the
Drosophila orthologs of TDP-43 and FUS, TBPH and caz, respec-
tively. The motor activities of larvae and adults in these models
were assessed to correlate potential defects in axonal transport
with locomotor deficits. We found that axonal transport defects
are common across all models tested, although they often
showed a differential effect between mitochondria and vesicle
cargos. Motor deficits were also common across the models,
though did not always show a clear correlation between the se-
verity of axonal transport defects and motor ability.
Results
Gain and loss of TDP-43 function have differential effects
on axonal transport
Mutations in TDP-43 cause ALS in an autosomal dominant man-
ner and likely impact on neuronal function in a multitude of
ways. We first analyzed whether ectopic expression of a patho-
genic variant of TDP-43, M337V, caused any disruption of axonal
transport in Drosophila motor nerves in comparison to TDP-
43WT. To minimize the likelihood of artifacts from different ex-
pression levels or from disruption of genomic insertion, we
made use of transgenes generated in the same integration site
and expressing at equivalent levels (see Materials and
Methods). Somewhat surprisingly no significant effect on mito-
chondrial transport was observed for any of the transgenes
(Fig. 1A). However, when we analyzed a different transport
cargo—vesicles loaded with GFP-fused neuropeptide Y
(NPY.GFP)—although TDP-43WT did not cause any significant de-
fects, TDP-43M337V expression caused a decrease in motility,
with a concomitant significant increase in the stationary frac-
tion (Fig. 1B). Overexpression of the fly homolog of TDP-43,
named TBPH, also interfered with the transport of vesicles but
not mitochondria (Fig. 1).
We next addressed whether TDP-43 normally plays a role in
axonal transport by examining whether loss of the endogenous
TBPH disrupted transport. We used a trans-heterozygous combi-
nation of the independently derived TBPH1 and the TBPHD23 dele-
tion mutants to avoid potential genetic background effects. Loss
of TBPH caused an overall increase in the stationary fraction of
mitochondria (Fig. 2A). Although there was an observable de-
crease in both anterograde and retrograde transport, this only
reached significance in the anterograde direction. In contrast, we
found no impact of loss of TBPH on vesicle transport (Fig. 2B).
Importantly, the disruption of mitochondrial transport could
be completely rescued by re-expression of a TBPHWT transgene
(Fig. 2A), verifying that this effect is a direct consequence of the
genetic loss of TBPH. Interestingly, the loss of mitochondrial
transport was also rescued by the ectopic expression of human
TDP-43WT and by the ALS-linked variant TDP-43M337V. This cross-
species rescue is consistent with previous reports and reflects
their close homology, but also reveals that the pathogenic variant
can broadly function as normal. Overall, these results indicate
that dysregulated TDP-43 expression can affect axonal transport
but cargoes are affected differently, and suggest that the patho-
genic mutation may increase the susceptibility to disease.
Axonal transport disruption in TDP-43models correlates
with behavioral deficits
A prime motivation for this study was to correlate disruptions in
axonal transport to decline in motor neuron function; the cardinal
clinical feature of ALS. Thus, flies were examined for their neuro-
muscular function using a number of assays. One indicator of se-
vere motor dysfunction is the inability of mutant flies to eclose
from the pupal case after undergoing metamorphosis. For TBPH
mutants, <40% of pupae produce viable adults (Fig. 3A), all of
whom died within 5 days (37,38). As a more direct measure, we
analyzed larval crawling and found that TBPH mutants exhibit a
significant motor deficit (Fig. 3B). Furthermore, the few adult mu-
tants that do eclose are uncoordinated and fail to register any
climbing capacity (Fig. 3C). These phenotypes could all be rescued
by the re-expression of either fly or human TDP-43 variants. For
eclosion and larval crawling, the phenotypes were rescued back to
control levels; however, the adult locomotion showed very limited
rescue suggesting that cell types other than motor neurons sub-
stantially contribute to this severe phenotype.
In contrast, the overexpression of the TBPH/TDP-43 has rela-
tively modest effects on motor function. Overexpression of
wild-type TBPH/TDP-43 does not perturb viability, larval crawl-
ing or climbing ability in young adult flies (Fig. 3D–F). However,
the ectopic expression of TDP-43M337V caused a modest loss of
larval locomotion but had a more pronounced effect on adult
climbing. Interestingly, when analyzed with age, the climbing
behavior in all three conditions progressively worsened, with
the effect of wild-type TBPH/TDP-43 overexpression eventually
mirroring that of the pathogenic mutant (Fig. 3F). Overall, these
findings support a relationship between the observed transport
defects and aberrant motor behavior.
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Loss or gain of caz causes broad axonal transport
disruption but gain of FUS specifically disrupts transport
of vesicles
We next sought to broaden our analysis and determine whether
axonal transport deficits were apparent in other models of ALS;
thus, we analyzed Drosophila models of FUS and its homolog
cabeza (caz). Ectopic expression of FUSWT or a pathogenic variant
FUSP525L caused no disruption to mitochondrial transport (Fig.
4A). However, the expression of both FUS variants led to an in-
crease in the stationary fraction of vesicles (Fig. 4B).
Interestingly, this appeared to be due to a selective decrease in
anterograde movement. In comparison, overexpression of cazWT
and the pathogenic equivalent cazP398L inhibited the transport of
both mitochondria and vesicles (Fig. 4C and D). Notably, al-
though both caz variants had a similar effect on vesicle
transport, the pathogenic variant had a substantially more
marked effect on mitochondrial transport.
Analyzing the caz1 null mutant, we found a significant de-
crease in the transport of both mitochondria and vesicles (Fig. 5A
and B). These phenotypes could be completely rescued by the re-
expression of cazWT (Fig. 5A and B). It is worth noting that although
vesicle transport was rescued by cazWT under standard conditions
(i.e. raised at 25 C), animals needed to be raised at 29 C, increas-
ing transgene expression levels, to see a complete rescue of the
mitochondrial transport. Interestingly, the re-expression of the
pathogenic variant, cazP398L, had differential rescuing effects.
Although it was able to rescue the mitochondrial transport defect,
it was unable to rescue the disruption in vesicle transport.
Similarly, expression of FUSWT was able to rescue the caz1 mutant
transport deficit of mitochondria and vesicles (Fig. 5C and D). We
also saw a strikingly similar effect from the FUSP525L variant as
Figure 1. Overexpression of TDP-43 affects the axonal transport of vesicles but not mitochondria. Live imaging analysis of (A) mitochondrial transport or (B) NPY con-
taining vesicles in Drosophila motor axons overexpressing either Drosophila TBPH or human TDP-43 variants. Mitochondria are marked by UAS-mito.GFP and vesicles by
UAS-NPY.GFP, driven by CCAP-GAL4. The number in brackets indicates the number of movies analyzed. Representative kymographs of the indicated genotypes are
shown. Control genotype; (A) CCAP-GAL4/þ; UAS-mito.GFP/UAS-lacZ, (B) CCAP-GAL4/þ; UAS-NPY.GFP/UAS-lacZ. Statistical analysis was performed using one-way
ANOVA with Sidak’s multiple comparison test: **P<0.01, ****P<0.0001. Charts show mean6SEM.
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observed for the equivalent cazP398L; the mitochondrial transport
was rescued but vesicle transport was not (Fig. 5C and D).
Axonal transport disruption in FUS/cazmodels
correlates with behavioral deficits
Analyzing the effects of FUS/caz mutations on motor ability, we
found that overexpression of either FUS or caz variants had al-
most no effect on eclosion, larval crawling or young adult loco-
motion (Fig. 6A–F). However, climbing ability began to decline
more rapidly in adults overexpressing the pathogenic FUSP525L
(Fig. 6C). Overexpression of either form of caz significantly per-
turbed motor ability to a similar extent (Fig. 6F).
caz1 mutants had a dramatic reduction in eclosion (Fig. 7A),
as reported previously (39). Larval crawling was also significantly
reduced, whereas the escaper adult mutants failed to
register any climbing activity, reminiscent of the TBPH mutants
(Fig. 7B and C). These phenotypes could be substantially rescued
by the re-expression of either cazWT or FUSWT as previously re-
ported (39). The pathogenic variant was also able to rescue
these phenotypes to a level similar to the wild-type version
(Fig. 7A–F).
caz overexpression rescues TBPHmotor function but not
axonal transport
TDP-43 and FUS, and their fly orthologs, have been shown to ge-
netically interact. The reduced viability and lifespan of TBPH
mutants were rescued by neuronal overexpression of caz,
whereas the locomotor deficit was partially rescued; however,
overexpression of TBPH did not alter the caz1 phenotypes (39). In
agreement with these findings, we also saw a complete rescue
of eclosion and adult climbing ability (Fig. 8A and C).
Figure 2. Loss of TBPH inhibits axonal transport of mitochondria but not vesicles. Live imaging analysis of (A) mitochondrial transport or (B) NPY containing vesicles in
Drosophila motor axons. Transheterozygous TBPH mutants were analyzed alone or in combination with transgenic expression of wild-type TBPH, or wild-type or a path-
ogenic variant of TDP-43. The number in brackets indicates the number of movies analyzed. Representative kymographs of the indicated genotypes are shown. Control
genotype; (A) CCAP-GAL4/þ; UAS-mito.GFP/UAS-lacZ, (B) CCAP-GAL4/þ; UAS-NPY.GFP/þ. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple
comparison test: *P<0.05, **P<0.01. Charts show mean6SEM.
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In light of this, we assayed whether the mitochondrial axo-
nal transport defect (Fig. 5) was also rescued. Surprisingly, the
transport defect in TBPH mutants was not rescued by overex-
pression of either cazWT or cazP398L (Fig. 8D). However, consistent
with this we found that larval crawling was not rescued by caz
expression (Fig. 8B). Therefore, it appears that although TBPH
and caz act within a genetic pathway influencing viability and
adult motor behaviors, this is not shared in the mechanisms
that disrupt axonal transport.
C9orf72-linked hexanucleotide repeats severely impair
transport but only mildly disrupts behavior
The third genetic model of ALS assessed in this study was the
C9orf72-associated hexanucleotide (GGGGCC [G4C2]) repeats.
Transgenic expression of a non-pathogenic repeat length
(G4C2-3) had no effect on mitochondrial transport; however, ex-
pression of 36 repeats (G4C2-36), previously shown to cause
neurotoxicity (30), caused a significant increase in the station-
ary fraction of mitochondria (Fig. 9A). To assess whether this
was due to RNA toxicity or the production of arginine-contain-
ing dipeptide repeats, we analyzed animals expressing ‘RNA-
only’ (RO-36) or proline–arginine encoding (PR-36) transcripts
(30) and found that this effect was specifically attributable to
the dipeptide repeats (Fig. 9A). Interestingly, vesicle transport
was already slightly disrupted by G4C2-3, which was not sub-
stantially increased by G4C2-36 expression (Fig. 9B). Although
the RO-36 repeats were again non-toxic, the expression of PR-36
caused a severe disruption of vesicle transport (Fig. 9B).
Despite the axonal transport phenotypes, neuromuscular
function appears to be only mildly affected. There were no
Figure 3. Gain and loss of TBPH/TDP-43 cause motor behavioral defects. TBPH mutants were analyzed alone or in combination with transgenic expression of wild-type
TBPH, or wild-type or a pathogenic variant of TDP-43, were assayed for (A) eclosion, (B) larval crawling, or (C) adult climbing ability. Transgenes were expressed in motor
neurons via the D42-GAL4 driver. Animals overexpressing TBPH or TDP-43 variants in a wild-type background were assayed for (D) eclosion, (E) larval crawling, or (F)
adult climbing ability. N (animals)100 (A, D), 20 (B, E), 50 (C, F). Control genotypes are TBPH1/þ; D42-GAL4/þ (A–C) and D42-GAL4/UAS-lacZ (D–F). The mutant geno-
type carries heterozygous D42-GAL4 in the background. Data in (C) and (F) are normalized to control. Statistical analysis was performed using one-way ANOVA with
Sidak’s multiple comparison test, except (C) and (F) which were analyzed by Kruskal–Wallis non-parametric test with Dunn’s correction: *P< 0.05, **P<0.01, ***P<0.001,
****P<0.0001. Comparisons in (C) are with control. Charts show mean6SEM.
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Figure 4. Overexpression of FUS or caz differentially inhibits mitochondrial and vesicle transport. Live imaging analysis of (A, C) mitochondrial transport and (B, D) vesi-
cle transport in Drosophila motor axons. Animals overexpressing wild-type or a pathogenic variant of FUS (A and B) or the Drosophila homolog caz (C and D) were ana-
lyzed. Representative kymographs of the indicated genotypes are displayed. The number in brackets indicates number of movies analyzed. Control genotype; (A, B)
CCAP-GAL4/þ; UAS-mito.GFP/UAS-lacZ, (C, D) CCAP-GAL4/þ; UAS-NPY.GFP/UAS-lacZ. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple
comparison test: *P<0.05, **P<0.01, ***P<0.001, ****P< 0.0001. Charts show mean6SEM.
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Figure 5. Loss of caz inhibits mitochondrial and vesicle transport. Live imaging analysis of (A, C) mitochondrial transport and (B, D) vesicle transport in Drosophila motor
axons. caz1 mutants were analyzed alone or in combination with transgenic expression of wild-type or a pathogenic variant of caz (A and B) or FUS (C and D) were ana-
lyzed. Representative kymographs of the indicated genotypes are shown. The number in brackets indicates the number of movies analyzed. Control genotype; (A, B)
CCAP-GAL4/þ; UAS-mito.GFP/lacZ, (C, D) CCAP-GAL4/þ; UAS-NPY.GFP/lacZ. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple comparison
test: *P<0.05, **P<0.01, ***P<0.001. Charts show mean6SEM.
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obvious effects on viability (data not shown), and the locomotor
capacity of larvae and young adults was modestly affected only
by PR-36 (Fig. 9C and D). Therefore, it seems that these disrup-
tions to axonal transport are reasonably well tolerated in young
flies, although a progressive aged-related decline in neuromus-
cular function was not tested.
Discussion
In this study we sought to determine whether disruption of axo-
nal transport is a common feature of ALS pathogenesis, which
may underlie the disruption of neuromuscular function and
loss of motor ability. The neuromuscular junction is highly en-
ergetically demanding and accordingly is dependent on correct
distribution and function of mitochondria (40). Thus, disruption
in mitochondrial transport has long been postulated to contrib-
ute to neuronal dysfunction, impacting on energy supply and
calcium buffering capacity at the neuromuscular junction.
Nonetheless, many other cellular components need to be trans-
ported to synapses to support proper functioning. Here, using
previously characterized Drosophila models of ALS, we exam-
ined the transport of two different cargos and correlated any
transport deficiencies with motor ability. Overall, we found that
axonal transport deficits are a common feature in all the models
analyzed here, but the severity and cargo selectivity differ sub-
stantially between models. Moreover, the severity of motor
deficits does not always mirror the severity of axonal transport
defects.
Gain and loss of TDP-43/TBPH exert differential effects on ax-
onal transport. The overexpression of TDP-43 variants did not
affect mitochondrial axonal transport but impaired vesicle
transport, whereas loss of TBPH caused a decrease in the trans-
port of mitochondria but vesicle transport was unaffected. The
relatively modest deficit in vesicle transport in the overexpres-
sion models correlated with modest locomotor deficits, whereas
the loss of mitochondrial transport in TBPH mutants correlated
with severe motor impairment.
Both gain and loss of function of FUS/caz affected axonal
transport, though the effects were generally more widespread.
Although the overexpression of caz variants affected both mito-
chondria and vesicle transport, overexpression of FUS variants
only perturbed vesicle transport. Loss of caz substantially af-
fected both vesicle and mitochondrial transport. The effects on
motor ability were similar to TDP-43/TBPH; although the caz mu-
tants exhibit severe developmental and locomotor defects, the
overexpression models have only modest effects on adult loco-
motion that become more pronounced with age.
Axonal transport was also disrupted in the C9orf72 models.
The expanded pure G4C2-36 repeats caused a disruption of mi-
tochondrial transport; however, the effect on the transport of
vesicles is more complicated as the G4C2-3 repeats also slightly
inhibit vesicles transport. Nevertheless, results from the RO-36
and PR-36 transgenes further support the view that toxicity of
Figure 6. Expression of FUS/caz variants has limited effect on motor behavior. Animals overexpressing wild-type or a pathogenic variant of FUS (A–C) or caz (D–F) in a
wild-type background were assayed for (A and D) eclosion, (B and E) larval crawling, or (C and F) adult climbing ability, driven by D42-GAL4. N (animals)100 (A, D), 20
(B, E), 50 (C, F). Control genotype is D42-GAL4/UAS-lacZ. Data in (C) and (F) are normalized to control. Statistical analysis was performed using one-way ANOVA with
Sidak’s multiple comparison test, except (C) and (F) which were analyzed by Kruskal–Wallis non-parametric test with Dunn’s correction: *P< 0.05, **P<0.01, ***P<0.001,
****P<0.0001. Charts show mean6SEM.
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these expanded repeats is caused by DPR production and not
‘RNA toxicity’ as the RO-36 transgene appeared inert in all as-
says whereas the PR-36 transgene was highly toxic, substan-
tially inhibiting mitochondrial and vesicle transport.
Interestingly, expression of this transgene caused only modest
motor deficits.
Thus, our data indicate that axonal transport deficits are a
common feature in all the models analyzed here. Disruption of
axonal transport has also been noted in several vertebrate
models of ALS, most notably in models of SOD1 mutations and
TDP-43 models. We chose to not investigate the impact of SOD1
mutations as they have been fairly well characterized in verte-
brates, and have been found to affect neurofilaments (31,32),
mitochondria (33) and vesicles (34). TDP-43 has been reported to
modestly affect axonal transport of mitochondria (35), although,
consistent with our observations, disruption of mitochondrial
transport was not substantiated in another study (8). To our
knowledge, our results are the first reporting an impact of FUS
or G4C2-repeats on axonal transport. Hence, our findings
confirm and extend the body of evidence indicating a general
impact of axonal transport deficits in diverse models of ALS. It
is also notable that in the vertebrate studies no clear pattern of
disruption has emerged, further supporting a more generalized
disruption of axonal transport.
Although this study has highlighted axonal transport deficits
as a common feature in Drosophila models of ALS, axonal trans-
port deficits are by no means specific to ALS because they have
also been observed in other disease models. Axonal transport
has been shown to be disrupted in models of Alzheimer’s dis-
ease (AD), polyglutamine (polyQ) diseases such as Huntington’s
disease, peripheral neuropathies and Parkinson’s disease (PD).
It is notable that the proteins in question in these disease mod-
els are all functionally quite different from each other and from
the ALS-related disease factors studied here, indicating that di-
verse mechanisms can disrupt axonal transport. The models of
AD implicate Tau-linked disruption of microtubules or dysregu-
lation of kinases and phosphatases to impair transport (41).
Huntingtin has been shown to interact with motor proteins via
Figure 7. Loss of caz causes reduced motor ability. caz1 mutants were analyzed alone or in combination with transgenic expression of wild-type or a pathogenic variant
of caz or FUS, driven by D42-GAL4. The indicated genotypes were assayed for (A and D) eclosion, (B and E) larval crawling, or (C and F) adult climbing ability. N (ani-
mals)100 (A, D), 20 (B, E), 50 (C, F). Control genotype is D42-GAL4/UAS-lacZ. The mutant genotype carries heterozygous D42-GAL4 in the background. Data in (C) and
(F) are normalized to control. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple comparison test, except (C) and (F) which were analyzed
by Kruskal–Wallis non-parametric test with Dunn’s correction: *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Charts show mean6SEM.
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HAP-1; however, axonal transport disrupted is also disrupted by
expanded polyQ in other disease contexts and thought to arise
indirectly from blockages caused by aggregated polyQ (42). A
wide array of mechanisms have been proposed for peripheral
neuropathies but many center on cytoskeleton, molecular mo-
tors and disruption of mitochondrial distribution and function
(43). Related to PD, an elegant mechanism has been elucidated
by which PINK1 and Parkin specifically regulate the transport of
mitochondria by regulating the turnover of the Miro–Milton
complex that connects mitochondria to kinesin (44). More re-
cently, mutations in LRRK2 have been shown interfere with
axonal transport by influencing the acetylation state of microtu-
bules, although the exact mechanisms are not clear (45). Thus,
it is clear that disturbances to multiple and diverse cellular pro-
cesses have the potential to disrupt axonal transport.
This study did not seek to determine the mechanism(s) of
axonal transport defects but emerging evidence strongly impli-
cates RNA dysregulation in TDP-43, FUS and G4C2-repeats
mechanisms. TDP-43 and FUS function as part of ribonucleopro-
tein complexes in the regulation of RNA metabolism, and dysre-
gulation leads to widespread effects on transcription and RNA
splicing and transport. A growing consensus proposes that
Figure 8. Overexpression of caz can rescue behavioral but not transport phenotypes in TBPH mutants. TBPH mutants were analyzed alone or in combination with trans-
genic expression of caz variants and assayed for (A) eclosion, (B) larval crawling and (C) adult climbing ability. (D) Live imaging analysis of mitochondrial transport in
Drosophila motor axons. The number in brackets indicates the number of movies analyzed and representative kymographs of the indicated genotypes are shown.
N (animals) 100 (A), 20 (B), 50 (C). Control genotypes; (A, B, C) D42-GAL4/UAS-lacZ, (D) CCAP-GAL4/þ; UAS-mito.GFP/þ. The mutant genotype carries heterozygous
D42-GAL4 in the background. Data in (C) are normalized to control. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple comparison test, ex-
cept (C) which was analyzed by Kruskal–Wallis non-parametric test with Dunn’s correction: *P< 0.05, **P<0.01, ****P<0.0001. Charts show mean6SEM.
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Figure 9. C9orf72-related dipeptide repeats inhibit axonal transport and cause a mild motor deficit. Animals expressing control length (G4C2-3) or expanded (G4C2-36)
hexanucleotide repeats, expanded RNA-only (RO-36) or proline-arginine dipeptide repeats (PR-36) were analyzed for axonal transport of (A) mitochondria, (B) vesicles,
or motor function as (C) larval crawling or (D) adult climbing ability. The number in brackets indicates the number of movies analyzed and representative kymographs
of the indicated genotypes are shown. N (animals)20 (C), 50 (D). Control genotypes; (A) CCAP-GAL4/þ;UAS-mito.GFP/þ, (B) CCAP-GAL4/þ; UAS-NPY.GFP/UAS-lacZ, (C,
D) D42-GAL4/UAS-lacZ. Data in (D) are normalized to control. Statistical analysis was performed using one-way ANOVA with Sidak’s multiple comparison test, except
(D) which was analyzed by Kruskal–Wallis non-parametric test with Dunn’s correction: *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Charts show mean6SEM.
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these RBPs sequester mRNAs in stress granules (46). Recent
work has revealed that TDP-43 and related RBPs form stress
granules via liquid–liquid phase separation (47). Moreover,
pathogenic mutations enhance the propensity for RBPs to fibril-
ize within these granules, which is proposed to interfere with
stress granule disassembly.
Both loss and gain of TDP-43 and FUS result in neurodegener-
ative phenotypes (48–51), indicating that correct levels of these
proteins are critical. Our results support the concept that the
stoichiometry of ribonucleoprotein complexes is a key factor,
and if the complex composition is altered functioning is im-
paired. Moreover, changes to the stoichiometry of ribonucleo-
protein complexes may result in differential effects on their
various targets; this may reflect the differences observed in the
cargos that are affected by different mutations.
Both TDP-43 and FUS have been shown to bind and regulate
RNAs of several motor proteins including KIF13 and KLC1 (7),
and KIF5C, KIF1B and KIF3A (13,52), respectively. KIF13 is a kine-
sin 3 motor involved in vesicle transport, whereas KIF5C, KIF1B
and KIF3A are involved in the axonal transport of mitochondria
and vesicles. KLC1 is a kinesin light chain, which interacts with
several kinesin heavy chain proteins. Interestingly, TDP-43 has
also been reported to bind the mRNA of TRAK1 (13), homologous
to Drosophila Milton, an adaptor protein that along with Miro
specifically mediates the binding of mitochondria to the motor
Kinesin 1 (53). Dysregulation of TRAK1/milton may underlie the
mitochondria-specific effect observed in TBPH mutants.
Although it is early days for understanding the mecha-
nism(s) by which C9orf72 G4C2 repeat expansions cause disease,
no clear picture is emerging that explains the selective neuronal
vulnerability. The formation of RNA foci from the expanded
G4C2 repeats again presents the possibility for wide-spread
RNA dysregulation as the pathogenic cause, but this seems un-
likely in light of the compelling observations from Drosophila
that arginine-containing DPRs are highly neurotoxic whereas
‘RNA only’ repeats are not (30). Furthermore, recent reports
have shown that inhibiting nuclear export of these repeats pre-
vents much of the toxicity (54–56). Thus, the effects of cytoplas-
mic DPR toxicity may more indirectly affect sensitive cellular
processes such as axonal transport. In summary, our findings
support axonal transport defects as a shared phenomenon in
multiple models of ALS, highlighting this as a potential com-
mon upstream target for therapeutic manipulation.
Materials and Methods
Drosophila genetics
Drosophila were raised under standard conditions at 25 C on
food consisting of agar, cornmeal, molasses and yeast unless
otherwise stated. The UAS transgenes for TBPH, TDP-43, caz and
FUS, which are all inserted in the attP2 landing site, as well as
the caz1 mutant were a gift from Brian McCabe (Columbia
University) (51). The TBPH1 line was a gift from Aaron Voigt
(RWTH Aachen University) (57) and the TBPHD23 a gift from
Fabian Feiguin (ICGEB, Trieste) (38). All C9orf72-related trans-
genic lines, which are all inserted in the attP40 landing site,
were a gift from Adrian Isaacs and Linda Partridge (University
College London) (30). UAS-NPY.GFP was a gift from Iain Robinson
(Plymouth University) (58). UAS-lacZ, UAS-mito.GFP, D42-GAL4
and CCAP-GAL4 were obtained from the Bloomington Drosophila
Stock Centre (Bloomington, IN).
Dissection and imaging of axonal transport
Analysis of axonal transport was performed live on third instar
larvae as previously described (45,59). Briefly, larvae were
pinned at each end dorsal side up to a Sylgard (Sigma 761028)
slide and covered in dissection solution: 128 mM NaCl, 1 mM
EGTA, 4 mM MgCl2, 2 mM KCl, 5 mM HEPES and 36 mM sucrose,
adjusted to pH 7.2. Larvae were cut along the dorsal midline us-
ing micro-dissection scissors, the sides pinned back and the in-
ternal organs removed. Movies were taken using an Olympus
FV1000 fluoview confocal microscope with a 60 water immer-
sion lens (NA 0.90 Olympus LUMPFL). Images were captured at a
rate of 1 frame per 5 s for 100 frames for mitochondria, or 1
frame per 0.5 s for 100 frames for vesicles. CCAP-GAL4 was used
as it expresses in a very sparse population of cells which secrete
the neuropeptide CCAP (Crustacean Cardio-Active Peptide).
These neurons send out a single axon in the segmental nerve
thus facilitating precise imaging of transport in an individual
axon.
Analysis of axonal transport
Movies were processed and analyzed using the ImageJ software
as previously described to produce kymographs (45). These
were used to manually score cargo as anterograde, retrograde or
stationary. Scoring was undertaken blind by two independent
researchers (K.R.B. and V.K.G.) and only concordant scores were
retained.
Eclosion
Pupae were placed in groups of 25 to a vial and the proportion of
adult flies that emerged was assessed. Animals from at least
three replicate crosses were analyzed.
Larval locomotion
Control and experimental crosses were established at 25 C and
transferred to fresh vials every 2 days. Vials containing wander-
ing third instar larvae were coded by an independent re-
searcher, placed at 23 C and left to acclimatize for 2 h.
Individual larvae were taken and rinsed in distilled water to re-
move any residual food, placed on a 2% agarose plate under a
viewing microscope and left to acclimatize for 5 s. The number
of peristaltic movements in 2 min was counted by direct obser-
vation. Animals from at least three replicate crosses were
analyzed.
Adult climbing
Male flies between 0 and 3 days post-eclosion were placed at 23 C
to acclimatize for 1 h. The flies were then transferred to the climb-
ing tubes at a maximum number of 25 per tube for a further 1 h.
Flies were introduced into a negative geotaxis counter-current ap-
paratus and given 10 s to climb at each position for total of five at-
tempts. A climbing index score was generated based on the
number of flies at each of the positions. The score for each geno-
type within an experiment was normalized to the control.
Animals from at least three replicate crosses were analyzed. For
the longitudinal study of the effects of age-related neurodegenera-
tion on climbing ability, male flies were aged in cohorts and the
climbing assay was performed at set time points as indicated.
Between assays, the flies were transferred every 2 days into fresh
vials with no more than 25 flies per vial.
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Statistical analysis
Calculations were performed using GraphPad Prism 6.0. Adult
climbing analysis is not normally distributed so the data were
analyzed using Kruskal–Wallis non-parametric test with Dunn’s
correction for multiple comparisons. All other quantifications
passed the D’Agostino & Pearson omnibus normality test. For
axonal transport, eclosion and larval crawling significance was
determined by one-way analysis of variance (ANOVA) with the
Sidak multiple comparison test (being more powerful than
Bonferroni’s correction).
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